• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIABETES CARE INC. FREE STYLE LIBRE 2 SENSORS; SENSOR, GLUCOSE, INVASIVE, NON-ADJUNCTIVE, FACTORY-CALIBRATED, USER-INITIATED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIABETES CARE INC. FREE STYLE LIBRE 2 SENSORS; SENSOR, GLUCOSE, INVASIVE, NON-ADJUNCTIVE, FACTORY-CALIBRATED, USER-INITIATED Back to Search Results
Device Problems Therapeutic or Diagnostic Output Failure (3023); Patient Device Interaction Problem (4001)
Patient Problem Hyperglycemia (1905)
Event Date 02/13/2023
Event Type  malfunction  
Event Description
Free style libre 2 devices i tried to use for 2 years from 2020 to 2022 did help initially to maintain my blood sugar by knowledge of my sugar; however the devices functioned worse and worse over time and the cost increased dramatically with medicare coverage to the point i could no longer use them.The devices fell off, would not even stick on as previously, despite my having been trained how to use them and successful use of them before.My blood sugars increased dramatically and my hba1c increased from 8.-% to 12.3% which my doctor feels is a significant adverse effect.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREE STYLE LIBRE 2 SENSORS
Type of Device
SENSOR, GLUCOSE, INVASIVE, NON-ADJUNCTIVE, FACTORY-CALIBRATED, USER-INITIATED
Manufacturer (Section D)
ABBOTT DIABETES CARE INC.
MDR Report Key16386376
MDR Text Key309759311
Report NumberMW5114978
Device Sequence Number1
Product Code PZE
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/15/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date06/30/2022
Was Device Available for Evaluation? No
Patient Sequence Number1
Treatment
LEVEMIR INSULIN; MELALEUCA VITAMINS; NOVOLOG INSULIN; PREGABALIN; TELMISARTAN
Patient Outcome(s) Other;
Patient Age73 YR
Patient SexFemale
Patient Weight83 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-